4.8 Article

Oxidized CaMKII causes cardiac sinus node dysfunction in mice

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 8, Pages 3277-3288

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI57833

Keywords

-

Funding

  1. NIH [R01 HL 079031, R01 HL 096652, R01 HL 070250, R01 HL 071140, RR026293, R00 HL 096805]
  2. European Union
  3. University of Iowa Research Foundation
  4. Transatlantic Alliance for CaMKII Signaling [08CVD01]
  5. European-North American Atrial Fibrillation Research Alliance [07CVD03]
  6. Heart Rhythm Society
  7. University of Iowa Cardiovascular Center
  8. AHA [10POST3620047]
  9. Gilead Sciences Research Scholars Program in Cardiovascular Disease

Ask authors/readers for more resources

Sinus node dysfunction (SND) is a major public health problem that is associated with sudden cardiac death and requires surgical implantation of artificial pacemakers. However, little is known about the molecular and cellular mechanisms that cause SND. Most SND occurs in the setting of heart failure and hypertension, conditions that are marked by elevated circulating angiotensin II (Ang II) and increased oxidant stress. Here, we show that oxidized calmodulin kinase II (ox-CaMKII) is a biomarker for SND in patients and dogs and a disease determinant in mice. In wild-type mice, Ang II infusion caused sinoatrial nodal (SAN) cell oxidation by activating NADPH oxidase, leading to increased ox-CaMKII, SAN cell apoptosis, and SND. p47(- -) mice lacking functional NADPH oxidase and mice with myocardial or SAN-targeted CaMKII inhibition were highly resistant to SAN apoptosis and SND, suggesting that ox-CaMKII-triggered SAN cell death contributed to SND. We developed a computational model of the sinoatrial node that showed that a loss of SAN cells below a critical threshold caused SND by preventing normal impulse formation and propagation. These data provide novel molecular and mechanistic information to understand SND and suggest that targeted CaMKII inhibition may be useful for preventing SND in high-risk patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available